Literature DB >> 10600542

Structural analysis of esp-1 gene (PRSS 21).

M Inoue1, M Isobe, T Itoyama, H Kido.   

Abstract

The esp-1 gene is originally cloned from human eosinophils and encodes a membrane-type serine protease. This gene is ubiquitously expressed in various tissues but not kidney or muscle, and highly expressed in testis. Among granulocytes, this gene is expressed in eosinophils but not neutrophils, although both are derived from myeloid progenitors. In the present study, we have cloned the esp-1 genome using a BAC library, and determined exon-intron junctions: This gene spans approximately 4.6 kb, and consists of 6 exons and 5 introns. On radiation hybrid and FISH analyses, the esp-1 gene was mapped to 16p13.3. In addition, we have cloned a new splicing variant form of esp-1 from a HeLa cell cDNA library, which contains many esp-1 clones. Both RNase protection and primer extension analyses revealed the transcription initiation site of the esp-1 gene is located at nucleotide position -106, residue G. Dual-luciferase reporter analysis revealed a GC-rich region between nucleotide positions, -106 and -189 containing one AP-1/Sp-1 binding site is responsible for the minimum promoter activity in HeLa cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600542     DOI: 10.1006/bbrc.1999.1870

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  High degree of conservation of the multigene tryptase locus over the past 150-200 million years of mammalian evolution.

Authors:  Jenny M Reimer; Paul B Samollow; Lars Hellman
Journal:  Immunogenetics       Date:  2010-04-10       Impact factor: 2.846

2.  Urokinase-type plasminogen activator is a preferred substrate of the human epithelium serine protease tryptase epsilon/PRSS22.

Authors:  Shinsuke Yasuda; Nasa Morokawa; G William Wong; Andrea Rossi; Mallur S Madhusudhan; Andrej Sali; Yuko S Askew; Roberto Adachi; Gary A Silverman; Steven A Krilis; Richard L Stevens
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

3.  Proteolytic activation of the protease-activated receptor (PAR)-2 by the glycosylphosphatidylinositol-anchored serine protease testisin.

Authors:  Kathryn H Driesbaugh; Marguerite S Buzza; Erik W Martin; Gregory D Conway; Joseph P Y Kao; Toni M Antalis
Journal:  J Biol Chem       Date:  2014-12-17       Impact factor: 5.157

4.  A novel serine protease predominately expressed in macrophages.

Authors:  Cailin Chen; Andrew L Darrow; Jian-Shen Qi; Michael R D'Andrea; Patricia Andrade-Gordon
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

Review 5.  Membrane-anchored serine proteases in health and disease.

Authors:  Toni M Antalis; Thomas H Bugge; Qingyu Wu
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

6.  Hypermethylation of the 5' CpG island of the gene encoding the serine protease Testisin promotes its loss in testicular tumorigenesis.

Authors:  K J Manton; M L Douglas; S Netzel-Arnett; D R Fitzpatrick; D L Nicol; A W Boyd; J A Clements; T M Antalis
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

7.  Targeting the membrane-anchored serine protease testisin with a novel engineered anthrax toxin prodrug to kill tumor cells and reduce tumor burden.

Authors:  Erik W Martin; Marguerite S Buzza; Kathryn H Driesbaugh; Shihui Liu; Yolanda M Fortenberry; Stephen H Leppla; Toni M Antalis
Journal:  Oncotarget       Date:  2015-10-20

8.  Testisin/Prss21 deficiency causes increased vascular permeability and a hemorrhagic phenotype during luteal angiogenesis.

Authors:  Raymond J Peroutka; Marguerite S Buzza; Subhradip Mukhopadhyay; Tierra A Johnson; Kathryn H Driesbaugh; Toni M Antalis
Journal:  PLoS One       Date:  2020-06-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.